Taylor Swift

Taylor Swift

Ask VT AI
View News Summary
  • UnitedHealth faces leadership crisis, market plunge, and regulatory scrutiny amid rising costs and a major cyberattack.
  • NFL pauses diversity program until 2026 to revamp and improve its effectiveness in increasing minority leadership roles.
  • Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • UnitedHealth faces leadership crisis, market plunge, and regulatory scrutiny amid rising costs and a major cyberattack.
  • NFL pauses diversity program until 2026 to revamp and improve its effectiveness in increasing minority leadership roles.
  • Exelixis and Ensysce report strong biotech advances, with Exelixis' cancer drug Cabometyx driving revenue growth and Ensysce's opioid-use-disorder drug PF9001 showing promise.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Taylor Swift